NewsbenzingaSpyre Therapeutics Q2 EPS $(0.36) Beats $(0.73) EstimateAug 4, 2026, 16:52 ET · PublishedSummaryOriginalView sourceArticle summaryPlease check the source for details.An excerpt from the original article.Related companiesSYRESYREView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…